10 Most Popular Stocks Among Hedge Funds – Q3
After each quarter, hedge funds and other major investors disclose many of their long equity positions with the U.S. Securities and Exchange Commission.
Posts Tagged ‘Jeffrey Ubben ValueAct Capital Management’
Valeant Pharmaceuticals Intl Inc (VRX), Motorola Solutions Inc (MSI): Is An Activist-Mimicking Mutual Fund A Smart Investment?
At Insider Monkey, we use a number of techniques to track investment activity by hedge funds and other notable investors.
This Metric Says You Are Smart to Buy Gardner Denver, Inc. (NYSE:GDI)
In the 21st century investor’s toolkit, there are a multitude of metrics market participants can use to watch their holdings.
Multiple Insiders Have Bought Valeant and These Healthcare Stocks
Stocks bought by insiders tend to outperform the market, and the effect is particularly strong when multiple insiders are buying (learn more about studies on insider trading).
Is Halliburton a Good Stock to Buy After Earnings?
Halliburton Company (NYSE:HAL) reported its results for the fourth quarter of 2012 on January 25th.
ValueAct’s Jeffrey Ubben’s Top Stock Picks Include Adobe Systems
Jeffrey Ubben is an activist investor, but a patient one; rather than agitate for immediate change and use the media to increase pressure on management, his preferred strategy...
State Street, General Dynamics, and More: Billionaire Thomas Steyer’s Cheap Stock Picks
Farallon Capital Management is one of the largest hedge funds in the world, with over $20 billion in assets under management at the beginning of 2012.
Jeff Ubben’s Wall Street Journal Op-Ed
Corporate America is stuck in a rut, and it is holding back economic growth.
Is Adobe a Good Stock to Buy?
Adobe Systems Incorporated (NASDAQ:ADBE) is most widely known for its Adobe Reader software, but the company’s other offerings have been built into a $16 billion market cap ...
Criterion Capital’s Top Stock Picks
Criterion Capital is a long/short investment fund that focuses on technology, media, and telecommunications investments.
Top Stock Picks by Long-Term Value Hedge Fund
Jeffrey Ubben founded ValueAct Capital and, since 2000, has served as its CEO and CIO.
Why is Blum Capital Downsizing its Position in This Real Estate Company?
In a recent filing, Richard Blum and Blum Capital Partners downsized its long-time stake in the commercial real estate services firm CBRE Group Inc. (NYSE:CBG).
Jeffrey Ubben’s Top Stock Picks
Jeffrey Ubben is the founder of ValueAct Capital and he has served as the Chief Executive Officer and Chief Investment Officer of the company since 2000.
Is $NYT a Good Deal or is a Competitor a Better? $GCI $MNI $WPO
The New York Times Company (NYT) publishes the New York Times, the popular national and regional paper.
Hedge funds Lose After Adobe $ADBE Shares Fall Nearly 11%
Shares of Adobe (ADBE) fell Wednesday after the company announced that it would no longer be focusing on making Flash for mobile browsers.
ValueAct Capital and Jeffrey Ubben’s Portfolio
Valueact Capital is founded by Jeffrey Ubben, 49 years old, in 2000.
25 Best Performing Hedge Funds in This Market Turmoil
Insider Monkey tracks more than 300 hedge funds and a few mutual funds with stellar reputation.
25 Best Hedge Funds of Q2 2011
Insider Monkey tracks 300+ hedge funds and several other prominent investors. We believe investors can beat the index funds by imitating best hedge funds' stock picks.
These Hedge Funds Lost a Bundle on La-Z-Boy and Adobe $LZB $ADBE
La-Z-Boy (LZB) shares declined nearly 12% today after Brian Sozzi -an analyst with Wall Street Strategies- cut his recommendation to hold.
Jeffrey Ubben, James Mitarotonda, Brevan Howard
Valeant Pharmaceuticals International’s $5.7 billion bid for drug maker Cephalon Inc.
